Beyfortus vs. Synagis for RSV Prevention in Children: 6 Differences Parents Should Know

• 2024

  Log in to bookmark this resource.

  Log in
• Alyssa Billingsley; Patricia Pinto-Garcia

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This website describes the differences between Beyfortus and Synagis, two injections used to prevent RSV in children. Beyfortus is recommended for more infants and lasts the entire RSV season with one dose, while Synagis requires monthly doses. Both are monoclonal antibodies but target different parts of the virus. Beyfortus provides higher levels of protection and is available through a program that offers it for free to eligible children. Side effects are generally mild for both medications, including injection site reactions and possible allergic responses. Parents should consult healthcare providers about which option is best for their child.

---

Tags

Focus Area: Infectious Disease

Audiences: Families & Children; Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Child, Preschool; Infant, Newborn; Respiratory Syncytial Virus Infections; Palivizumab

Institutions: GoodRx

---

More like this

Vaccine Education Center None · Children's Hospital of Philadelphia Pertussis (Whooping Cough) 2024 · Pediatric Pandemic Network (PPN) G7 Major Initiatives None · Gulf 7 - Pediatric Disaster Network (G7)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---